SCHEMBL1704141

SCHEMBL1704141

CCC(CC)(C(=O)O)C(=O)Oc1ccc(C=O)c(OC)c1

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 4/20 0.55
L3MBTL1 Q9Y468 1/20 0.45
MAPT P10636 3/20 0.43
MEN1 O00255 1/20 0.43
KMT2A Q03164 1/20 0.43
NPC1 O15118 1/20 0.40
RAB9A P51151 1/20 0.40
SMN1; SMN2 Q16637 1/20 0.40
LY96 Q9Y6Y9 1/20 0.40
BACE1 P56817 1/20 0.40
TRIM24 O15164 1/20 0.40
TYR P14679 1/20 0.40
TRIM33 Q9UPN9 1/20 0.40
CYP1A1 P04798 3/20 0.40
CYP1B1 Q16678 3/20 0.40
CYP1A2 P05177 1/20 0.40
TNFRSF1A P19438 1/20 0.39
MAOB P27338 2/20 0.39
ERN1 O75460 1/20 0.39
LMNA P02545 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29136541 0.78 ALDH1A1 (0.71) ALDH1A1L3MBTL1MAPTMEN1KMT2A
SCHEMBL4182791 0.78 ALDH1A1 (0.61) ALDH1A1L3MBTL1MAPTMEN1KMT2A
SCHEMBL29136540 0.77 ALDH1A1 (0.73) ALDH1A1L3MBTL1MAPTMEN1KMT2A
SCHEMBL1704772 0.76 ALDH1A1 (0.36) ALDH1A1L3MBTL1MAPTMEN1KMT2A
SCHEMBL3292760 0.75 ALDH1A1 (0.71) ALDH1A1L3MBTL1MAPTMEN1KMT2A
SCHEMBL29669441 0.73 ALDH1A1 (0.63) ALDH1A1L3MBTL1MAPTMEN1KMT2A
SCHEMBL3292757 0.73 ALDH1A1 (0.63) ALDH1A1L3MBTL1MAPTMEN1KMT2A
SCHEMBL156656 0.73 MAOB (0.38) ALDH1A1MAPTNPC1RAB9ASMN1; SMN2
SCHEMBL96291 0.73 ALDH1A1 (1.00) ALDH1A1L3MBTL1MAPTMEN1KMT2A
SCHEMBL11782313 0.73 ALDH1A1 (0.54) ALDH1A1L3MBTL1MAPTMEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2441763-A1 Benzylpiperazine derivatives useful for the treatment of gastrointestinal disorders Glaxo Group Limited (GB) 2012-04-18 EP disclosed